F 0883
Develop and implement policies and procedures for flu and pneumonia vaccinations.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to follow their policy and procedure (P&P) for pneumococcal
vaccination for one of six sampled residents (Resident 1). Resident 1 pneumococcal vaccine (vaccination to
protect resident from pneumococcal disease) was not offered and not administered in accordance with the
current Center for Disease Control and Prevention (CDC) recommendations. This deficient practice had the
potential for acquiring pneumococcal disease for Resident 1.
Residents Affected - Few
Findings:
Review of Resident 1's face sheet (a document that gives a resident's information at a quick glance)
indicated Resident 1 admitted to facility on 5/23/2023 with diagnoses including diabetes mellitus type 2 (a
chronic condition that affects the way the body processes blood sugar), sepsis (condition in which the body
responds to an infection), and protein calorie malnutrition (deficiency of energy, protein and other nutrients
causes measurable adverse effects on body function and clinical outcome). Resident 1 had an assigned
resposible party (RP- person acting on behalf of the resident for day-to-day decision making for resident)
for decison making.
Review of Resident 1's physician orders dated 5/23/2023 indicated Pneumococcal vaccine upon admission
and as needed unless it was already been given/or medically contraindicated.
Review of Resident 1's minimum data set (MDS, a clinical assessment tool) assessment dated [DATE]
indicated Resident 1 was not a candidate for interview with a short term and long-term memory problem.
Review of Resident 1's electronic medical record immunization report indicated Resident 1 received
pneumococcal conjugate vaccine 13 (PCV 13: type of vaccine used to protect adults against pneumonia)
on 5/23/2023. There was no indication that Resident 1 received pneumococcal polysaccharide vaccine 23
(PPSV 23: vaccine protects against 23 types of bacteria that cause pneumococcal disease) 8 weeks after
taken PCV 13 as recommended by CDC.
Review of CDC pneumococcal vaccine timing for adults 65 years or older indicated For adults with an
immunocompromising condition (when people's immune system was not working as well as it should to
protect from infection), the minimum interval for PPSV 23 was 8 weeks or more than 8 weeks since last
PCV13 dose.
Review of CDC pneumococcal vaccination: summary of who and when to vaccinate indicated, increased
risk of exposure to pneumococcal infections among people 65 years or older, who are living in nursing
homes or other long-term care facilities, and chronic medical condition such as diabetes.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055388
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055388
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
San Jose Healthcare & Wellness Center
75 N. 13th Street
San Jose, CA 95112
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0883
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During a concurrent interview and record review with facility's infection preventionist (IP) on 8/1/2023 at
1:40 p.m., IP stated she was not aware of CDC's recommendations for PPSV23 to offer/administer 8 weeks
after received dose of PCV13 for residents who are immunocompromised. IP confirmed Resident 1
received dose of PCV 13 ten weeks ago at the acute hospital before she came to facility on 5/23/2023 and
did not offer PPSV 23 after 8 weeks. IP stated Resident 1 was immunocompromised due to her diagnosis
of diabetes and currently living in a long-term care nursing facility. IP also stated she would informed
Resident 1's physician and RP. IP also provide PPSV 23 this week if they both agree with CDC's
recommendations.
Review of facility's P&P titled, Pneumococcal Disease Prevention, date revised 2/18/2021, the P&P
indicated, The facility will offer pneumococcal immunization to each Resident, according to Center for
Disease Control and Prevention (CDC) recommendations, unless it is medically contraindicated, or the
Resident has already been immunized.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055388
If continuation sheet
Page 2 of 2